PD

Petr Denisov

Investment Analysis | Biotechnology | ClinicalTrials | Feasibility |

Haifa District

VC

Invests in

Sectors:

Locations:

  • Min Investment:

    $0.00

  • Max Investment:

    $3.00

  • Target Investment:

    $1.00

Skills

Emergency Medicine
Cardiovascular Physiology
Infectious Diseases
Contract Negotiation
Medical Monitoring
Business Strategy
Venture Capital
Biopharmaceuticals
Due Diligence
Clinical Trials
Protocol
Clinical Monitoring
ICH-GCP
CTMS
CRO
GCP
Therapeutic Areas
Clinical Development
EDC
Feasibility Studies

Education

Work Experience

CP
Confidence Pharmaceutical Research

2024

  • Medical Monitor

    2024

UC
Unicorn Capital Partners

2019 - 2024

  • Managing Partner

    2019 - 2024

EI
Engene Inc

2017 - 2020

  • Board Observer

    2017 - 2020

Pharmstandard Ventures (ex Inbio Ventures)

2014 - 2020

  • Medical Expert

    2014 - 2020

    ○ Pharmaceutical market evaluation ○ Due diligence and scientific expertise ○ Forecasting

TI
TransMedics, Inc.

2019 - 2019

  • Member Board Of Directors

    2019 - 2019

SR
Synergy Research Group (SynRG)

2013 - 2014

  • Director, Business Development

    2013 - 2014

    ○ Feasibility assessment; ○ Project management (pulmonology; bioequivalence; oncology; cardiovascular) ○ Client relations, contract negotiations

WC
Worldwide Clinical Trials

2006 - 2013

  • Associate Director, Feasibility

    2006 - 2013

    ○ Managing feasibility process (all studies – all therapeutic areas) ○ Maintaining the feasibility database and the WCT project registry ○ Project management (pulmonology, pharmacoeconomic)

different institutions

1999 - 2006

  • different positions

    1999 - 2006

    different roles in biomedical sciences and other areas